Insider Transactions in Q1 2025 at Cytek Biosciences, Inc. (CTKB)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 18
2025
|
Wenbin Jiang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,004
-0.04%
|
$10,020
$5.31 P/Share
|
|
Feb 18
2025
|
Wenbin Jiang PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,758
+0.13%
|
-
|
|
Feb 18
2025
|
Ming Yan CHIEF TECHNOLOGY OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
588
-0.01%
|
$2,940
$5.31 P/Share
|
|
Feb 18
2025
|
Ming Yan CHIEF TECHNOLOGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,981
+0.03%
|
-
|
|
Feb 18
2025
|
Valerie Barnett CHIEF LEGAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
786
-1.21%
|
$3,930
$5.31 P/Share
|
|
Feb 18
2025
|
Valerie Barnett CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,016
+3.01%
|
-
|